Prostate Cancer

Prostate Cancer - Treatment Options

An individual's treatment path for prostate cancer is determined after assessing the risk level of your disease. Treatment paths are also greatly influenced by age and lifestyle of an individual with prostate cancer. For example, a 40 year old man diagnosed with early stage & low-risk prostate cancer may still decide to opt for a robotic prostatectomy to eliminate lifelong surveillance / watchful waiting. Then again, another 40 year old man may choose to forgo active treatment, and regularly monitor to check for progression of the disease.

Read more about Prostate Cancer - Treatment Options

Prostate Cancer - Diagnosis

For men with an abnormal PSA, there are now additional tests that may be considered before prostate needle biopsy. These include prostate Magnetic Resonance Imaging (MRI) and other genomic tests such as the 4k test and the Prostate Health Index (PHI).

Read more about Prostate Cancer - Diagnosis

Prostate Cancer - Risks & Causes

Older age is a risk factor for prostate cancer. Autopsy studies have shown that 30% of men in the 5th decade of life have evidence of prostate cancer versus 50% of men in the 8th decade of life. In the United States, 60% of men with prostate cancer are diagnosed after the age of 65 years.

Read more about Prostate Cancer - Risks & Causes

Prostate Cancer

Prostate cancer is the second leading cause of cancer-related death in men. However, many men who are diagnosed with prostate cancer may be at low risk. Urologists at Weill Cornell Medicine help you understand your risks, and will provide evaluation for your specific circumstances. When pursuing treatment, we offer the most advanced treatment options including surgery, radiation therapy, and androgen deprivation therapy.

Read more about Prostate Cancer

Peter N. Schlegel

Dr. Schlegel is an internationally acclaimed expert in the treatment of male infertility, especially the interface of male factor treatment with assisted reproductive techniques. His work has also clarified the importance of hormonal therapy, sperm analysis and genetic studies in the evaluation of men with infertility. He was awarded the 1996 Established Clinician Award by The European Society for Human Reproduction and Embryology.

Read more about Peter N. Schlegel

Brady Urologic Health Center

The Brady Urologic Health Center is located within an 8,000 square foot suite on the ninth floor of the Starr Pavilion at Weill Cornell Medicine/New York-Presbyterian Hospital and is composed of a close-knit team of physicians, working together to provide treatment for the broad spectrum of urologic conditions.